Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

ClinicalTrials.gov ID: NCT00634049

Public ClinicalTrials.gov record NCT00634049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the efficacy and safety of isavuconazole in the treatment of renally impaired participants with invasive fungal infections caused by Aspergillus and participants with invasive fungal disease caused by rare fungi.

Study identification

NCT ID
NCT00634049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
149 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2008 (Actual)
Primary completion
Jan 3, 2014 (Actual)
Completion
May 5, 2016 (Actual)
Last update posted
Dec 11, 2024

2008 – 2016

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
City Of Hope National Medical Center Duarte California 91010 —
University of California Davis Health System Sacramento California 95817 —
California Pacific Medical Center San Francisco California 94110 —
University of California at San Francisco San Francisco California 94143 —
Stanford University Hospital Stanford California 94303 —
University Of Colorado Health Sciences Center Aurora Colorado 80045 —
Emory Hospital Atlanta Georgia 30322 —
University of Chicago, Division of Infectious Diseases Chicago Illinois 60637 —
Indiana BMT Beech Grove Indiana 46107 —
Infectious Disease of Indiana Indianapolis Indiana 46280 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Brigham & Womens Hospital Boston Massachusetts 02115 —
UMASS Memorial Medical Center Worcester Massachusetts 01655 —
Wayne State University School of Medicine Detroit Michigan 48201 —
Henry Ford Hospital Detroit Michigan 48202 —
University of Minnesota Minneapolis Minnesota 55455 —
Upstate Infectious Diseases Association LLP Albany New York 12208 —
Cleveland Clinic Cleveland Ohio 44195 —
Regional Infection Diseases Infusion Center Inc. Lima Ohio 45801 —
Temple University Health Sciences Philadelphia Pennsylvania 19140 —
University of Pittsburgh Medical Center Health System Pittsburgh Pennsylvania 15213 —
University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Fred Hutchinson Cancer Research Center, Clinical Research Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00634049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00634049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →